Uniplan Investment Counsel, Inc. Collegium Pharmaceutical, Inc Transaction History
Uniplan Investment Counsel, Inc.
- $943 Million
- Q3 2025
A detailed history of Uniplan Investment Counsel, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Uniplan Investment Counsel, Inc. holds 112,028 shares of COLL stock, worth $5.15 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
112,028
Previous 130,425
14.11%
Holding current value
$5.15 Million
Previous $3.86 Million
1.63%
% of portfolio
0.42%
Previous 0.42%
Shares
9 transactions
Others Institutions Holding COLL
# of Institutions
258Shares Held
37.6MCall Options Held
53.7KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$266 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.83MShares$130 Million1.63% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.39MShares$110 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$102 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.6MShares$73.5 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.57B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...